|
IeDEA West Africa Renewal 3
|
5U01AI069919-13
|
$225,000
|
|
DABIS, FRANCOIS
|
ADERA
|
|
HIV/HPV Cancer Prevention, Treatment & Pathogenesis: Rwanda/Einstein Consortium
|
5U54CA190163-05
|
$701,988
|
$56,159
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
RCT of An Internet Cessation Program Plus Online Social Network for HIV + Smokers
|
5R01CA192954-05
|
$626,669
|
|
SHUTER, JONATHAN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Practical high resolution microscopy of un-cut, un-embedded lung biopsies
|
5R44CA189522-03
|
$692,728
|
|
LEVENE, MICHAEL
|
APPLIKATE TECHNOLOGIES, LLC
|
|
WalkIT: Neighborhood walkability and moderation of adaptive walking interventions
|
5R01CA198915-04
|
$568,727
|
|
ADAMS, MARC
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Charge sensitive optical detection for high-throughput study of small molecules
|
5R33CA202834-03
|
$378,392
|
|
TAO, NONGJIAN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Role of SLC13A3 in Renal Cell Carcinoma
|
5F31CA210612-03
|
$29,664
|
|
JORDAN, ANDRE
|
AUGUSTA UNIVERSITY
|
|
Integrative Molecular Epidemiology of Neurocognitive Outcomes in Acute Lymphoblastic Leukemia
|
1K07CA218362-01A1
|
$166,043
|
|
BROWN, AUSTIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis
|
3R01CA190776-04S1
|
$116,456
|
|
EL-SERAG, HASHEM
|
BAYLOR COLLEGE OF MEDICINE
|
|
Dynamic effects of cancer mutations on the mammalian SWI/SNF ATPase Brg
|
5R00CA187565-04
|
$249,000
|
|
HODGES, HAMILTON
|
BAYLOR COLLEGE OF MEDICINE
|
|
Cognitive Change after Proton RT vs. Photon or Surgery for Pediatric Brain Tumor
|
5R01CA187202-05
|
$577,030
|
|
KAHALLEY, LISA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-12
|
$3,203,119
|
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Tumor Suppressor Localization and Function at the Peroxisome
|
5R01CA143811-10
|
$356,625
|
|
WALKER, CHERYL
|
BAYLOR COLLEGE OF MEDICINE
|
|
New Vulnerabilities in MYC-Driven Breast Cancer
|
1R01CA215226-01A1
|
$598,309
|
|
WESTBROOK, THOMAS
|
BAYLOR COLLEGE OF MEDICINE
|
|
Epigenetic damage in women living in LA food-desert zip codes
|
5R01CA220693-02
|
$700,834
|
|
SEEWALDT, VICTORIA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Risk factors for molecular subtypes of NHL a prospective evaluation
|
5R01CA202712-03
|
$668,277
|
|
WANG, SOPHIA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Functional analysis of BRCA1 in DNA damage response and tumor suppression
|
5R01CA187209-05
|
$352,750
|
|
YU, XIAOCHUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Basic and Translational studies of Ras-mutant colorectal cancer
|
5R01CA178017-05
|
$359,556
|
|
HAIGIS, KEVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Directed Purinergic Signaling as Immunotherapy in Leukemia
|
1R21CA221702-01A1
|
$228,375
|
|
ROBSON, SIMON
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Elucidating a Novel Mechanism for SPOP in Suppressing Prostate Tumorigenesis
|
5K99CA212292-02
|
$168,804
|
|
ZHANG, JINFANG
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Role of m6A mRNA methylation in Neuroblastoma
|
5R21CA219352-02
|
$191,227
|
|
GREGORY, RICHARD
|
BOSTON CHILDREN'S HOSPITAL
|
|
Lymphocyte Function Associated Antigens
|
5R01CA031798-38
|
$581,719
|
|
SPRINGER, TIMOTHY
|
BOSTON CHILDREN'S HOSPITAL
|
|
Development of novel selective Rac inhibitors for refractory leukemias
|
5R01CA202756-03
|
$560,804
|
|
WILLIAMS, DAVID
|
BOSTON CHILDREN'S HOSPITAL
|
|
Identification of susceptibility to chemotherapy induced peripheral neuropathy using patient stem cell derived sensory neurons
|
5R03CA220219-02
|
$88,500
|
|
WOOLF, CLIFFORD
|
BOSTON CHILDREN'S HOSPITAL
|
|
An assessment of whether aspirin and/or vitamin D improves breast cancer outcomes in Black women and the modifying effect of genetic variants
|
5K01CA212056-02
|
$133,775
|
|
BETHEA, TRACI
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Molecular Mechanisms Regulating the Alternative Lengthening of Telomeres Pathway
|
5R01CA201446-03
|
$377,438
|
|
FLYNN, RACHEL
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
PAX3 pathways in melanoma
|
5R01CA184001-05
|
$377,438
|
|
LANG, DEBORAH
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Developing miR-10b targeting for glioblastoma
|
1R01CA215072-01A1
|
$408,884
|
|
KRICHEVSKY, ANNA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Exploring mechanisms to increase cancer cell antigenicity by modulating lineage-specific transcription in tumors
|
5R03CA212987-02
|
$78,830
|
|
WIDLUND, HANS
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer Biology Training Grant
|
5T32CA059366-23
|
$246,088
|
|
JACKSON, MARK
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Treatment of glioblastoma using chain-like nanoparticles
|
5U01CA198892-04
|
$561,808
|
|
KARATHANASIS, EFSTATHIOS
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Imaging Liver Cancer Proliferation
|
5R01CA204373-03
|
$378,195
|
|
LEE, ZHENGHONG
|
CASE WESTERN RESERVE UNIVERSITY
|
|
The Role of FOXCI in Basal-like Breast Cancer
|
2R01CA151610-06
|
$415,527
|
|
CUI, XIAOJIANG
|
CEDARS-SINAI MEDICAL CENTER
|
|
High-throughput palmitoyl-proteomics profiling of extracellular vesicles for identification of biomarkers for early detection of clinically significant prostate cancer
|
5R01CA218526-02
|
$384,283
|
|
DI VIZIO, DOLORES
|
CEDARS-SINAI MEDICAL CENTER
|
|
Statin Intervention to Slow the Time to Hepatocellular Carcinoma Recurrence in Cirrhotics Awaiting Liver Transplantation
|
5R01CA218486-02
|
$661,266
|
|
HUSSAIN, SHEHNAZ
|
CEDARS-SINAI MEDICAL CENTER
|
|
Predicting the diagnosis of pancreatic cancer by leveraging big data
|
1R21CA220073-01A1
|
$203,197
|
|
JEON, CHRISTIE
|
CEDARS-SINAI MEDICAL CENTER
|
|
Cancer-Associated Fibroblasts Alter the Composition of B cells in Solid Malignancies
|
5R01CA208753-03
|
$400,313
|
|
ORSULIC, SANDRA
|
CEDARS-SINAI MEDICAL CENTER
|
|
The Mechanism of Tumor Formation in Beckwith-Wiedemann Syndrome
|
5K08CA193915-04
|
$140,504
|
|
KALISH, JENNIFER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Implementation of Survivorship Care Plans for Adolescent and Young Adult Survivors of Childhood Cancer: Stakeholder Perspectives of Barriers and Facilitators
|
1R21CA219371-01A1
|
$198,733
|
|
SCHWARTZ, LISA
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Understanding the niche of minimal residual disease leukemia cells
|
2R01CA172896-06
|
$402,563
|
|
KIM, YONG-MI
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Longitudinal, multimodal assessment of neuropsychological functioning in children diagnosed with high-risk acute lymphoblastic leukemia (HR-ALL): Using early changes to predict later impairment
|
5R01CA212190-02
|
$374,232
|
|
HARDY, KRISTINA
|
CHILDREN'S RESEARCH INSTITUTE
|
|
Automated Activities of Daily Living (ADL) Adherence System to Reduce Complications After Intensive Cancer Therapy in Pediatrics
|
1R21CA223503-01A1
|
$207,495
|
|
DANDOY, CHRISTOPHER
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Cold Spring Harbor Laboratory Cancer Workshops
|
5R25CA009481-35
|
$316,782
|
|
GRODZICKER, TERRI
|
COLD SPRING HARBOR LABORATORY
|
|
From pathogenesis to new therapeutic targets in Diffuse Large B cell Lymphoma
|
5R35CA210105-03
|
$960,000
|
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The Role of Androgens on Breast Cancer Susceptibility across the Lifecourse.
|
1K07CA218166-01A1
|
$161,902
|
|
HOUGHTON, LAUREN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Inflammation, Physical Activity, and Colon Cancer Recurrence and Survival
|
5K99CA218603-02
|
$139,840
|
|
BROWN, JUSTIN
|
DANA-FARBER CANCER INST
|
|
Tumor and host markers of clinical outcomes after MIBG therapy in neuroblastoma
|
1R01CA214912-01A1
|
$629,914
|
|
DUBOIS, STEVEN
|
DANA-FARBER CANCER INST
|
|
Structure-Function Analysis of a Novel Inhibitory Mechanism for Pro-Apoptotic BAK
|
5F31CA210590-03
|
$44,524
|
|
HAUSEMAN, ZACHARY
|
DANA-FARBER CANCER INST
|
|
Data-driven approaches to identify biomarkers and regulators of cancer drug resistance
|
1K99CA218900-01A1
|
$100,000
|
|
JIANG, PENG
|
DANA-FARBER CANCER INST
|
|
The Role of EglN1 and HIF in Normal Hematopoiesis and in Leukemia
|
5R00CA181488-05
|
$249,000
|
|
LOSMAN, JULIE
|
DANA-FARBER CANCER INST
|
Total relevant funding to Penis for this search: $575,211
|